KWF Lead4Life PPP 2026

€5,000,000 total||Up to 4 years

Lead-212 radiopharmaceuticals PPP

Last seen in a scan/import: 3 Jul 2026.

Catalog updated: 4 Jul 2026.

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

Closed for now. See which open grants match your research. 30s, no email. See my matches →

The KWF Lead4Life PPP funds cancer research partnerships combining academic and industry expertise to develop Lead-212 radiopharmaceuticals, with grants of €300,000-€1,500,000 per consortium over up to four years. This is a one-off call from KWF structured as a public, private partnership, targeting applied and translational projects ready to move toward clinical use. Consortia must include at least one commercial partner; academic groups and clinicians are encouraged to team with industry to advance patient-ready tools.

Details

Funder	KWF
Budget	€5,000,000 total
Duration	Up to 4 years
Consortium	Required — PPP
Application	Single stage
TRL	Applied / industrial
Frequency	One-off

Who Should Apply

•Academic cancer researchers with Lead-212 radiopharmaceutical projects ready for translation
•Consortia including at least one industry or SME partner (mandatory for PPP)
•Clinical teams with nuclear medicine, oncology, or molecular imaging expertise
•Research groups based at Dutch academic or hospital institutions
•Projects at applied TRL (6-8) with a clear pathway to patient benefit

Key Dates

•Deadline: 9 September 2026
•Single-stage application
•Up to four-year project duration

Tips for Applicants

✓Industry partnership strength is decisive in PPP evaluation, secure a named, committed co-applicant from a pharmaceutical, biotech, or diagnostic company before submission.
✓Lead-212 specificity is essential; proposals on other alpha-emitters or broad radiopharmaceutical platforms will not fit this call.
✓Include a translational roadmap with regulatory milestones (e.g. GMP manufacturing plan, IND timeline); KWF expects clinical-phase pathway, not proof-of-concept.

Frequently Asked Questions

What is the budget for the KWF Lead4Life PPP?

Grants range from €300,000 to €1,500,000 per consortium over the project duration.

Do I need a company partner to apply for the KWF Lead4Life PPP?

Yes, this is a public, private partnership call; consortia must include at least one industry, SME, or commercial partner.

How long is the KWF Lead4Life PPP project?

Projects run for up to four years from award.

Is this a one-time call?

Yes, the KWF Lead4Life PPP is a one-off call with a single deadline in 2026; there is no indication of future rounds.

What is the focus of the KWF Lead4Life PPP?

The call funds development of Lead-212 radiopharmaceuticals for cancer treatment, targeting projects at applied and translational technology readiness levels.

cancer-biologykwfradiopharmaceuticalstranslational-researchppp-consortiumlead-212netherlandsclinical-translation